Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Opna Bio Announces 2025 ASH Presentations Highlighting Preclinical Data from Novel Protein Degrader Program and Updated Interim Data from Phase 1 Combination Study of OPN-2853 with Ruxolitinib in Advanced Myelofibrosis

Summary by Enid News & Eagle
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 4, 2025-

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

Opna Bio Announces 2025 ASH Presentations Highlighting Preclinical Data from Novel Protein Degrader Program and Updated Interim Data from Phase 1 Combination Study of OPN-2853 with Ruxolitinib in Advanced Myelofibrosis

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 4, 2025-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Tuesday, November 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

South San Francisco icon

South San Francisco

News
For You
SearchBlindspotLocal